logo-loader
viewUltraCharge Ltd

Lithex Resources drilling to target tin and tantalum at Moolyella Project

au_tin_99_pure_4ee03f3476893.jpg

Lithex Resources (ASX: LTX) has commenced drilling at its Moolyella Project within the highly prospective Pilbara Goldfield of Western Australia, targeting tin, tantalum and other rare metal bearing pegmatites.

Lithex plans to drill a total of up to 3000 metres across the hard rock pegmatite and eluvial targets at Pegmatite Gully and Eluvial Gully, located 23 kilometres east-northeast of Marble Bar.

In addition, the company has commenced an Auger sampling program across the existing tailing dumps and overburden stockpiles to better understand the metallurgical content of the material as well as the thickness and volume. Lithex will also utilise this method to evaluate unmined alluvial leads.

The tenements cover the Moolyella Tin Field where continuous mining activities were ongoing from their initial discovery in 1898 to 1986.  From 1986 limited small scale intermittent mining has been carried out on the field.

Lithex was admitted to the ASX following a successful IPO which offered 10 million shares at $0.20 to raise $2 million on May 17, 2011. The company had A$3.1 million cash at the end of the September quarter.

Quick facts: UltraCharge Ltd

Price: 0.002 AUD

ASX:UTR
Market: ASX
Market Cap: $2.25 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Futura Medical sees 'potentially quicker route to market' for its erectile...

Futura Medical PLC's (LON:FUM) executive director and head of R&D Ken James speaks to Proactive London's Andrew Scott following the read-out from the phase III clinical trial of its erectile dysfunction gel. James says while MED2005 showed strong efficacy, excellent safety and rapid speed...

59 minutes ago

2 min read